The conference “Innovative Preclinical Models for Pediatric Cancer Research” (DMM26) is a specialized scientific meeting scheduled for October 13–15, 2026.

Organized by the Company of Biologists, this event focuses on the development and application of advanced models – including organoids, PDX models, and CRISPR-engineered systems – to better understand childhood cancers and accelerate drug discovery. The program features world-renowned experts such as Caroline Hutter, Martine Roussel, and Sam Behjati, and emphasizes cross-disciplinary collaboration between basic scientists and clinicians to address the unique challenges of pediatric oncology.